Lifei Nie

Eng koʻp iqtibos qilingan asarlar

1. Design, combinatorial synthesis and cytotoxic activity of 2-substituted furo[2,3-d]pyrimidinone and pyrrolo[2,3-d]pyrimidinone library202221 iqtibos
2. Design, synthesis, in vitro evaluation of a new pyrrolo[1,2‐<i>a</i>]thiazolo[5,4‐<i>d</i>]pyrimidinone derivatives as cholinesterase inhibitors against Alzheimer's disease202218 iqtibos
3. Parallel synthesis of condensed pyrimidine-thiones and their antitumor activities202218 iqtibos
4. <scp>2‐substituted</scp> tricyclic oxazolo[5,4‐<i>d</i>]pyrimidine library: Design, synthesis, and cytotoxicity activity202112 iqtibos
5. Synthesis and anticancer activity of ethyl 5‐amino‐1‐<i>N</i>‐substituted‐imidazole‐4‐carboxylate building blocks202111 iqtibos
6. Furo[2,3‐<i>d</i>]pyrimidines as Mackinazolinone/Isaindigotone Analogs: Synthesis, Modification, Antitumor Activity, and Molecular Docking Study202310 iqtibos
7. Synthesis of tricyclic pyrazolopyrimidine arylidene ester derivatives and their cytotoxic and molecular docking evaluations202410 iqtibos
8. Novel pyrazolo[3,4-d]pyrimidines as potential anticancer agents: Synthesis, VEGFR-2 inhibition, and mechanisms of action20229 iqtibos
9. Synthesis of Novel 7-Phenyl-2,3-Dihydropyrrolo[2,1-b]Quinazolin-9(1H)-ones as Cholinesterase Inhibitors Targeting Alzheimer’s Disease Through Suzuki–Miyaura Cross-Coupling Reaction20257 iqtibos
10. Discovery of novel (E)-1-methyl-9-(3-methylbenzylidene)-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2-a]pyrimidin-4(1H)-one as DDR2 kinase inhibitor: Synthesis, molecular docking, and anticancer properties20236 iqtibos

Hammualliflar

1. Khurshed Bozorov17 ta umumiy asar2021–2025
2. Jiangyu Zhao17 ta umumiy asar2021–2025
3. Haji Akber Aisa15 ta umumiy asar2021–2025
4. Rustamkhon Kuryazov9 ta umumiy asar2022–2025
5. Buer Song7 ta umumiy asar2021–2025
6. Zukela Ruzi5 ta umumiy asar2021–2025
7. Chao Niu4 ta umumiy asar2022–2025
8. Zarifa Murtazaeva4 ta umumiy asar2025
9. Azizbek Nasrullaev3 ta umumiy asar2025
10. Yan Zeng3 ta umumiy asar2021–2024

Barcha hammualliflar →